Eli Lilly & Co. vs. Ocular Therapeutix, Inc.
Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| LLY | OCUL | |
|---|---|---|
| Market Cap | $1.03 trillion | $1.68 billion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| LLY | OCUL | |
|---|---|---|
| Dividend Yield | 0.60% | — |
LLY and OCUL split the dividend factors evenly.
Risk & Sentiment
| LLY | OCUL | |
|---|---|---|
| Short Interest | 1.29% | 1.47% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, OCUL overview, OCUL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
